Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 19, 2010European Journal of Clinical InvestigationOpen Access

Osteopontin as a novel prognostic marker in stable ischaemic heart disease: a 3‐year follow‐up study

View Full Paper
Ask AI
Bookmark
Share

Authors

ΠΓΠαναγιώτα ΓεωργιάδουOnassis Cardiac Surgery CenterEIEfstathios K. IliodromitisNational and Kapodistrian University of AthensFΚFotios ΚolokathisNational and Kapodistrian University of Athens

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Γεωργιάδου et al. (2010) studied this question.

synapsesocial.com/papers/6a70506035aa2c282ce19db4https://doi.org/10.1111/j.1365-2362.2010.02257.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cardiac biomarkers and acute coronary syndromes — The Euro Heart Survey of Acute Coronary Syndromes Experience2003 · 60 citations
  2. 2Myocardial Osteopontin Expression Is Associated With Left Ventricular Hypertrophy1997 · 150 citations
  3. 3Myocardial Osteopontin Expression Coincides With the Development of Heart Failure1999 · 145 citations
  4. 4Vascular Calcification2004 · 867 citations
  5. 5Osteopontin as a Potential Diagnostic Biomarker for Ovarian Cancer2002 · 509 citations